1. Home
  2. CWEN vs MRUS Comparison

CWEN vs MRUS Comparison

Compare CWEN & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWEN
  • MRUS
  • Stock Information
  • Founded
  • CWEN 2012
  • MRUS 2003
  • Country
  • CWEN United States
  • MRUS Netherlands
  • Employees
  • CWEN N/A
  • MRUS N/A
  • Industry
  • CWEN Electric Utilities: Central
  • MRUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CWEN Utilities
  • MRUS Health Care
  • Exchange
  • CWEN Nasdaq
  • MRUS Nasdaq
  • Market Cap
  • CWEN 3.4B
  • MRUS 2.7B
  • IPO Year
  • CWEN 2013
  • MRUS 2016
  • Fundamental
  • Price
  • CWEN $28.87
  • MRUS $40.90
  • Analyst Decision
  • CWEN Strong Buy
  • MRUS Strong Buy
  • Analyst Count
  • CWEN 6
  • MRUS 14
  • Target Price
  • CWEN $34.33
  • MRUS $87.00
  • AVG Volume (30 Days)
  • CWEN 874.5K
  • MRUS 770.0K
  • Earning Date
  • CWEN 04-30-2025
  • MRUS 05-07-2025
  • Dividend Yield
  • CWEN 5.93%
  • MRUS N/A
  • EPS Growth
  • CWEN 20.79
  • MRUS N/A
  • EPS
  • CWEN 0.79
  • MRUS N/A
  • Revenue
  • CWEN $1,406,000,000.00
  • MRUS $54,732,000.00
  • Revenue This Year
  • CWEN $10.50
  • MRUS $26.81
  • Revenue Next Year
  • CWEN $8.32
  • MRUS $23.85
  • P/E Ratio
  • CWEN $36.31
  • MRUS N/A
  • Revenue Growth
  • CWEN 9.08
  • MRUS 42.77
  • 52 Week Low
  • CWEN $24.02
  • MRUS $33.19
  • 52 Week High
  • CWEN $31.09
  • MRUS $61.61
  • Technical
  • Relative Strength Index (RSI)
  • CWEN 50.91
  • MRUS 45.06
  • Support Level
  • CWEN $28.12
  • MRUS $37.92
  • Resistance Level
  • CWEN $29.06
  • MRUS $46.36
  • Average True Range (ATR)
  • CWEN 0.72
  • MRUS 2.58
  • MACD
  • CWEN -0.01
  • MRUS -0.27
  • Stochastic Oscillator
  • CWEN 48.80
  • MRUS 35.31

About CWEN Clearway Energy Inc. Class C

Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Share on Social Networks: